Spruce Biosciences Inc has announced a revised schedule for its regulatory submission of TA-ERT, a potential treatment for Sanfilippo syndrome type B. While the ...

The session Next-Generation Drug Development Enabled by Automation, Digitalization, and AI/ML is scheduled to take place at Pittcon 2026 in San Antonio, TX, on Monday, March 9, from 8:30 am–10:40 am ...

Psychedelic drug development can still benefit from the FDA Commissioner’s National Priority Review Voucher Pilot Program, though the CNPV designation was not given to Compass Pathways’ synthetic ...

FDA leadership is emphasizing one adequate, well-controlled trial plus confirmatory evidence as a default pathway, with ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...

For those that hoped artificial intelligence would help to deliver drugs that actually work, the hope lives on. Here, Dr Raminderpal Singh reflects on the sobering reality check that 2025 delivered to ...

Freedom from the Robinson-Patman Act Is Never More Than One Generation Away from Extinction AI Laws Need a Kill Switch The Great Inversion Unicorns in Sweden The Duty to Say What the Law Is Capping ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...